SCNI
Scinai Immunotherapeutics Ltd. - American Depositary Shares (SCNI)
$79
About Scinai Immunotherapeutics Ltd. - American Depositary Shares (SCNI)
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.
Details
Daily high
$0.80
Daily low
$0.74
Price at open
$0.74
52 Week High
$6.18
52 Week Low
$0.70
Market cap
673,900
Dividend yield
0.00%
Volume
50,454
Avg. volume
61,080
P/E ratio
-.06
Scinai Immunotherapeutics Ltd. - American Depositary Shares News
Details
Daily high
$0.80
Daily low
$0.74
Price at open
$0.74
52 Week High
$6.18
52 Week Low
$0.70
Market cap
673,900
Dividend yield
0.00%
Volume
50,454
Avg. volume
61,080
P/E ratio
-.06